Federal Judge’s Uncertainty Reveals Complexity in Generic Drug Appeal

An irascible Federal Circuit judge expressed frustration during a recent session concerning a generic endocrine disorder drug. During the proceedings, the judge pointedly accused one attorney of “beating a straw man to death.” Nevertheless, she admitted to remaining undecided on the appeal’s outcome. This judicial ambivalence underscores the potential complexity and contentious nature of the case. For further details, refer to the coverage by Law360.